Klasser M - Search Results

1

Alfacalcidol in the therapy of renal bone disease.

Ritzerfeld M, Klasser M, Mann H. Ritzerfeld M, et al. Among authors: klasser m. Int J Clin Pharmacol Ther. 2001 Dec;39(12):546-50. doi: 10.5414/cpp39546. Int J Clin Pharmacol Ther. 2001. PMID: 11770836 Clinical Trial.

2

Safety monitoring of a polyvalent immunoglobulin preparation: documentation of 15,548 administrations.

Struff WG, Klasser M, Eckert V, Dietrich RL. Struff WG, et al. Among authors: klasser m. Int J Clin Pharmacol Ther. 2005 Sep;43(9):420-8. doi: 10.5414/cpp43420. Int J Clin Pharmacol Ther. 2005. PMID: 16163894

3

Oxaceprol is as effective as diclofenac in the therapy of osteoarthritis of the knee and hip.

Bauer HW, Klasser M, von Hanstein KL, Rolinger H, Schladitz G, Henke HD, Gimbel W, Steinbach K. Bauer HW, et al. Among authors: klasser m. Clin Rheumatol. 1999;18(1):4-9. doi: 10.1007/s100670050043. Clin Rheumatol. 1999. PMID: 10088941 Clinical Trial.

4

Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac.

Herrmann G, Steeger D, Klasser M, Wirbitzky J, Fürst M, Venbrocks R, Rohde H, Jungmichel D, Hildebrandt HD, Parnham MJ, Gimbel W, Dirschedl H. Herrmann G, et al. Among authors: klasser m. Clin Rheumatol. 2000;19(2):99-104. doi: 10.1007/s100670050025. Clin Rheumatol. 2000. PMID: 10791619 Clinical Trial.

5

Oxaceprol--a randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug.

Krüger K, Klasser M, Mössinger J, Becker U. Krüger K, et al. Among authors: klasser m. Clin Exp Rheumatol. 2007 Jan-Feb;25(1):29-34. Clin Exp Rheumatol. 2007. PMID: 17417987 Clinical Trial.

6

Remineralisation of carious enamel lesions after application of a CHX/F-mouthrinse compared with sole CHX- and placebo-application.

Altenburger MJ, Klasser M, Schirrmeister JF, Hellwig E. Altenburger MJ, et al. Among authors: klasser m. Oral Health Prev Dent. 2006;4(4):255-63. Oral Health Prev Dent. 2006. PMID: 17153647 Clinical Trial.

7

[Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].

Jost WH, Klasser M, Reichmann H. Jost WH, et al. Among authors: klasser m. Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. doi: 10.1055/s-2008-1038249. Epub 2008 Oct 2. Fortschr Neurol Psychiatr. 2008. PMID: 18833504 German.

8

In situ fluoride retention and remineralization of incipient carious lesions after the application of different concentrations of fluoride.

Altenburger MJ, Schirrmeister JF, Lussi A, Klasser M, Hellwig E. Altenburger MJ, et al. Among authors: klasser m. Eur J Oral Sci. 2009 Feb;117(1):58-63. doi: 10.1111/j.1600-0722.2008.00585.x. Eur J Oral Sci. 2009. PMID: 19196319 Clinical Trial.

9

Fluoride uptake and remineralisation of enamel lesions after weekly application of differently concentrated fluoride gels.

Altenburger MJ, Schirrmeister JF, Wrbas KT, Klasser M, Hellwig E. Altenburger MJ, et al. Among authors: klasser m. Caries Res. 2008;42(4):312-8. doi: 10.1159/000148164. Epub 2008 Jul 29. Caries Res. 2008. PMID: 18663301 Clinical Trial.

10

Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim--correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF.

Lehmacher W, Klasser M, Duering A. Lehmacher W, et al. Among authors: klasser m. Support Care Cancer. 2016 May;24(5):1935-1937. doi: 10.1007/s00520-016-3116-3. Epub 2016 Feb 10. Support Care Cancer. 2016. PMID: 26860847 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page